Infectious Vaccines Market by Product, Infectious Disease, End User

List of Tables

The Infectious Vaccines Market was valued at USD 30.01 billion in 2023, expected to reach USD 31.83 billion in 2024, and is projected to grow at a CAGR of 8.98%, to USD 54.83 billion by 2030.

Infectious vaccines are biological preparations that provide immunity against various infectious diseases by stimulating the body's immune response. The necessity for infectious vaccines is paramount due to their critical role in preventing disease outbreaks, reducing morbidity and mortality, and achieving herd immunity. The application of these vaccines spans public health programs, individual immunizations, and global health initiatives targeting diseases such as influenza, hepatitis, measles, and COVID-19. The end-use scope includes government healthcare departments, hospitals, clinics, and research institutions, all of which utilize vaccines for mass immunization campaigns and individual preventive care. Key growth factors influencing the infectious vaccines market include increasing awareness of preventive healthcare, technological advancements in vaccine development, government initiatives for immunization, and the robust funding for vaccine research. Emerging opportunities in the market are driven by the development of novel vaccines, such as mRNA-based vaccines and multi-valent vaccines, which offer potential during pandemics or against rapidly mutating viruses. Companies can capitalize on these opportunities by investing in research and securing partnerships with governmental and non-governmental organizations to expand vaccine distribution networks. However, the market faces limitations and challenges such as high R&D costs, stringent regulatory frameworks, and vaccine hesitancy among populations, which can inhibit market growth. Innovative areas for growth include personalized vaccines, thermostable vaccines that mitigate cold chain challenges, and needle-free delivery systems that enhance ease of use. Market insights also indicate a shift towards digital platforms for vaccine distribution and monitoring, which can optimize supply chains and post-vaccination follow-ups. The nature of the infectious vaccines market is dynamic and highly competitive, necessitating continuous innovation and adaptation to changing public health environments and emerging diseases.

KEY MARKET STATISTICS
Base Year [2023]	USD 30.01 billion
Estimated Year [2024]	USD 31.83 billion
Forecast Year [2030]	USD 54.83 billion
CAGR (%)	8.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infectious Vaccines Market

The Infectious Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- High prevalence of chronic diseases including HIV, cancer, diabetes
- Government focused activities to control epidemic diseases
- Rising consumer awareness and expenditure regarding health
Market Restraints
- High costs and longer timelines required for vaccine production
Market Opportunities
- Growing investment by public & private sector for R&D endeavors
- Introduction of novel infectious vaccines
Market Challenges
- Possibilities of vaccine side effects and adverse events

Porter's Five Forces: A Strategic Tool for Navigating the Infectious Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infectious Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infectious Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infectious Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infectious Vaccines Market

A detailed market share analysis in the Infectious Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infectious Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infectious Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infectious Vaccines Market

A strategic analysis of the Infectious Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infectious Vaccines Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma, Inc., AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech, Biological E Ltd., CSL Limited, DAIICHI SANKYO COMPANY, LIMITED, Emergent BioSolutions Inc., GlaxoSmithKline PLC, Incepta Vaccine, Ltd., Johnson and Johnson Services Inc., Lonza Group AG, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis International AG, Novavax, Inc., Pfizer, Inc., Sanofi SA, Serum Institute of India Pvt., Ltd, and Sinovac Biotech Ltd..

Market Segmentation & Coverage

This research report categorizes the Infectious Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Preventive Vaccine and Therapeutic Vaccine.
Based on Infectious Disease, market is studied across Allergy, Cervical Cancer, DTP, Hepatitis, Influenza, Meningococcal, MMR, Pneumococcal, Polio, Rotavirus, and Varicella.
Based on End User, market is studied across Adults and Pediatrics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-ED54C46E8F6D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. High prevalence of chronic diseases including HIV, cancer, diabetes
  - 5.1.1.2. Government focused activities to control epidemic diseases
  - 5.1.1.3. Rising consumer awareness and expenditure regarding health
- 5.1.2. Restraints
  - 5.1.2.1. High costs and longer timelines required for vaccine production
- 5.1.3. Opportunities
  - 5.1.3.1. Growing investment by public & private sector for R&D endeavors
  - 5.1.3.2. Introduction of novel infectious vaccines
- 5.1.4. Challenges
  - 5.1.4.1. Possibilities of vaccine side effects and adverse events
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Infectious Vaccines Market, by Product

6.1. Introduction
6.2. Preventive Vaccine
6.3. Therapeutic Vaccine

7. Infectious Vaccines Market, by Infectious Disease

7.1. Introduction
7.2. Allergy
7.3. Cervical Cancer
7.4. DTP
7.5. Hepatitis
7.6. Influenza
7.7. Meningococcal
7.8. MMR
7.9. Pneumococcal
7.10. Polio
7.11. Rotavirus
7.12. Varicella

8. Infectious Vaccines Market, by End User

8.1. Introduction
8.2. Adults
8.3. Pediatrics

9. Americas Infectious Vaccines Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Infectious Vaccines Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Infectious Vaccines Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. Astellas Pharma, Inc.
3. AstraZeneca PLC
4. Bavarian Nordic A/S
5. Bharat Biotech
6. Biological E Ltd.
7. CSL Limited
8. DAIICHI SANKYO COMPANY, LIMITED
9. Emergent BioSolutions Inc.
10. GlaxoSmithKline PLC
11. Incepta Vaccine, Ltd.
12. Johnson and Johnson Services Inc.
13. Lonza Group AG
14. Merck & Co., Inc.
15. Mitsubishi Tanabe Pharma Corporation
16. Novartis International AG
17. Novavax, Inc.
18. Pfizer, Inc.
19. Sanofi SA
20. Serum Institute of India Pvt., Ltd
21. Sinovac Biotech Ltd.